This inventor holds 1 USPTO granted patent. Top assignee: Chiron Behring Gmbh & Co.. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: Matthias Niedrig: Innovator in HIV Research
Introduction
Matthias Niedrig is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of HIV research through his innovative work on selected peptides of the HIV gag protein. His research aims to develop effective inhibitors for the HIV virus, showcasing his commitment to advancing medical science.
Latest Patents
Matthias Niedrig holds a patent for the preparation of selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (HIV). This invention specifically relates to the peptide sequence NPGLLETSEGCRQ, which has demonstrated the ability to inhibit HIV. His work in this area is crucial for developing potential therapeutic options for those affected by the virus.
Career Highlights
Throughout his career, Matthias has been associated with Chiron Behring GmbH & Co., where he has collaborated with other experts in the field. His dedication to research and innovation has positioned him as a key figure in the fight against HIV.
Collaborations
Matthias has worked alongside esteemed colleagues such as Susanne Modrow and Hans Joachim Wolf. Their combined expertise has contributed to the advancement of research in HIV and related fields.
Conclusion
Matthias Niedrig's contributions to HIV research through his patented innovations highlight the importance of scientific inquiry in addressing global health challenges. His work continues to inspire future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile